IL279752B
(en )
2022-12-01
Polycyclic compounds and their use in the treatment of immune disorders
SI3240554T1
(en )
2019-12-31
Blautia stercosis and wexlerae for use in the treatment of inflammatory and autoimmune diseases
IL295859B2
(en )
2025-07-01
Factor xi antibodies and methods of use
RS59625B1
(en )
2020-01-31
ANTI-IL-17A ANTIBODIES AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
IL262092A
(en )
2018-11-29
Human anti-pacap antibodies and their use
HUE053296T2
(en )
2021-06-28
Anti-TFR antibodies and their use in the treatment of proliferative and inflammatory disorders
PL3353210T3
(en )
2025-02-24
Anti-TIGIT antibodies and methods of use
IL251970B
(en )
2021-12-01
Anti-cd79b antibodies and methods of use
EP3359171C0
(en )
2023-07-05
USE OF AKKERMANSIA MUCINIPHILA IN THE TREATMENT OF INFLAMMATORY DISEASES
PT3148579T
(en )
2021-03-11
ANTI-GITR ANTIBODIES AND METHODS OF THEIR USE
SI3491025T1
(en )
2024-02-29
FCRN ANTIBODIES AND THEIR METHODS OF USE
LT3353212T
(en )
2021-12-27
OPTIMIZED ANTI-CD3 BISPECIAL ANTIBODIES AND THEIR USE
RS62568B1
(en )
2021-12-31
PD-1-BINDING MOLECULES AND METHODS OF THEIR USE
RS64768B1
(en )
2023-11-30
FCRN ANTIBODIES AND METHODS OF THEIR USE
LT3295951T
(en )
2020-09-25
ANTI-PVRIG ANTIBODIES AND METHODS OF USE
IL252026B
(en )
2021-10-31
Antibodies against complement factor c1q of human origin and uses thereof
SI3356408T1
(en )
2020-07-31
Humanized antibodies to human CD19 and methods of administration
IL251128A0
(en )
2017-04-30
Bispecific antibodies and methods of use in ophthalmology
RS63956B1
(en )
2023-02-28
HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF THEIR USE
LT3532499T
(en )
2021-08-10
ANTIBODIES TO IL-33 AND THEIR USE
HUE050095T2
(en )
2020-11-30
Treatment of metabolic disorders in equidae
SI3134124T1
(en )
2019-06-28
The IGF-1R antibody conjugate and its use for the treatment of cancer
HRP20180260T1
(en )
2018-03-09
BUPRENORPHINE DIMER AND ITS USE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS
SI3359563T1
(en )
2019-11-29
Antigen receptors and their use
HUE054093T2
(en )
2021-08-30
Anti-HtrA1 antibodies and methods of their use